Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Soft Tissue Sarcoma”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Early research (Phase 1)Ended earlyNCT01258634
What this trial is testing

Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

Who this might be right for
OsteosarcomaLung Metastases
University of Chicago 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562480
What this trial is testing

Radiation Therapy Before Surgery for Localized, Resectable Soft Tissue Sarcoma of the Extremity and Superficial Trunk

Who this might be right for
Resectable Soft Tissue SarcomaStage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8+2 more
Mayo Clinic 120
Testing effectiveness (Phase 2)Study completedNCT02300545
What this trial is testing

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

Who this might be right for
Sarcoma, Soft TissueSoft Tissue Sarcoma
Washington University School of Medicine 56
Testing effectiveness (Phase 2)Looking for participantsNCT03965234
What this trial is testing

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Who this might be right for
Metastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more
Roswell Park Cancer Institute 99
Not applicableUnknownNCT05739084
What this trial is testing

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS

Who this might be right for
Soft Tissue Sarcomas
Centre Leon Berard 300
Early research (Phase 1)Study completedNCT00004123
What this trial is testing

Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma

Who this might be right for
Sarcoma
M.D. Anderson Cancer Center 36
Early research (Phase 1)Study completedNCT02783599
What this trial is testing

Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 51
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT01048723
What this trial is testing

Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas

Who this might be right for
Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)UnknownNCT05602415
What this trial is testing

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaHigh Risk of RecurrenceAnlotinib+1 more
Ruijin Hospital 41
Testing effectiveness (Phase 2)Study completedNCT00356031
What this trial is testing

Bevacizumab and Radiation Therapy for Sarcomas

Who this might be right for
Soft Tissue SarcomaFibrous HistiocytomaLiposarcoma+3 more
Massachusetts General Hospital 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07823491
What this trial is testing

Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall

Who this might be right for
Resectable LiposarcomaResectable Soft Tissue SarcomaResectable Undifferentiated Pleomorphic Sarcoma
Ohio State University Comprehensive Cancer Center 228
Not applicableUnknownNCT00072488
What this trial is testing

Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaNeuroblastomaSarcoma
American College of Radiology Imaging Network 226
Testing effectiveness (Phase 2)UnknownNCT00753727
What this trial is testing

Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Australasian Sarcoma Study Group 26
Testing effectiveness (Phase 2)WithdrawnNCT00003273
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more
NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT03651375
What this trial is testing

Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall

Who this might be right for
SarcomaFibrosarcomaLeiomyosarcoma+14 more
Maria Sklodowska-Curie National Research Institute of Oncology 46
Testing effectiveness (Phase 2)Study completedNCT02357810
What this trial is testing

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

Who this might be right for
Adult LiposarcomaMetastatic LiposarcomaMetastatic Osteosarcoma+4 more
Northwestern University 178
Not applicableUnknownNCT05684874
What this trial is testing

Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaAdult Soft Tissue SarcomaResectable Soft Tissue Sarcoma
Centre Leon Berard 25
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT04420975
What this trial is testing

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcoma+27 more
Jonsson Comprehensive Cancer Center 14
Next Page